相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Synthetic peptide corresponding to the C-terminal region of human α-Dystroglycan.
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
-20°C
- 克隆性:
Monoclonal
- 标记物:
Unconjugated
- 适应物种:
Human, Mouse, Rat (predicted)
- 保质期:
12 months from the shipping date of the product.
- 抗原来源:
Human
- 目录编号:
ERB0418
- 级别:
Primary Antibodies
- 库存:
Available
- 供应商:
Elucigen Biosciences
- 宿主:
Rabbit
- 应用范围:
ICC, IHC, WB
- 浓度:
0.5 mg/mL
- 靶点:
Q14118
- 抗体英文名:
Anti-α-Dystroglycan Recombinant Rabbit Monoclonal Ab
- 抗体名:
Anti-α-Dystroglycan Recombinant Rabbit Monoclonal Ab
- 规格:
25μg/100μg/500μg
| 规格: | 25μg | 产品价格: | ¥860.0 |
|---|---|---|---|
| 规格: | 100μg | 产品价格: | 询价 |
| 规格: | 500μg | 产品价格: | 询价 |
Alpha-dystroglycan (α-DG) is a glycoprotein that plays a key role in the dystrophin-glycoprotein complex (DGC), which is essential for maintaining the structural integrity of muscle cells and other tissues. α-DG is the extracellular subunit of the dystroglycan complex and functions as a receptor that binds to the extracellular matrix (ECM), particularly to laminin, a key protein in the basement membrane. This interaction helps to stabilize muscle cell membranes and facilitate communication between the intracellular cytoskeleton and the ECM. α-DG is heavily glycosylated at its extracellular domain, and these glycosylation modifications are critical for its function, enabling it to interact with ECM components. Mutations or defects in α-DG's structure or glycosylation can lead to muscular dystrophies and other related disorders, such as limb-girdle muscular dystrophy and Walker-Warburg syndrome. These conditions are often characterized by muscle weakness, defects in tissue architecture, and impaired cellular signaling.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Bozzi, M. et al. (2009) Matrix Biol 28, 179-87.
技术资料暂无技术资料 索取技术资料
文献支持
Anti-α-Dystroglycan Recombinant Rabbit Monoclonal Ab
¥860





